IP Library Granted Patent US 7,196,180
Granted Patent B2
US 7,196,180 · App. 10/680,000 · Granted Mar 27, 2007

Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same

Assignee: Orthogene LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,196,180
App. No.
10/680,000
Granted
Mar 27, 2007
Kind
B2
Abstract

Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.

Claims (16)

1. A method for making a derivative of hyaluronic acid (HA), comprising the steps of:

a) forming an activated ester at a carboxylate of a glucuronic acid moiety of hyaluronic acid;

b) substituting at the carbonyl carbon of the activated ester formed in step (a), a side chain comprising a nucleophilic portion and a functional group portion; and

c) forming a cross-linked hydrogel from the functional group portion of the hyaluronic acid derivative in solution under physiological conditions wherein the forming of a cross-linked hydrogel is not by photo-cross-linking.

2. The method of claim 1 , wherein the nucleophilic portion is selected from the group consisting of primary amine, and secondary amine.

3. The method of claim 1 , wherein the functional group portion is selected from the group consisting of active ester, aldehyde, amine, hydrazide, maleimide, sulfhydryl, and peptide.

4. The method of claim 1 , wherein step (a) is performed with an active ester selected from the group consisting of a substituted triazole, N-sulfosuccinimide, nitrophenol, partially halogenated phenol, perhalophenol, pentafluorophenol, HOBT, and NHS, by carbodiimide-mediated coupling.

5. The method of claim 1 , wherein step (c) is performed in situ in a patient in need of tissue repair.

6. A method for forming a matrix for a temporary scaffold for tissue repair according to the method of claim 1 , wherein a crosslinker is used in step c), and wherein the crosslinker is selected from the group consisting of polyvalent active ester, aldehyde, amine, maleimide, and sulihydryl.

7. A method for forming a matrix for a temporary scaffold for tissue repair according to the method of claim 1 , wherein the HA derivative comprises a peptide substrate for transglutaminase, and wherein the HA derivative is crosslinked using transglutaminase.

8. The method of claim 1 , wherein step (c) is performed in the presence of cells.

9. The method of claim 1 , wherein step (c) is performed in the presence of at least one member selected from the group consisting of growth factors, cytokines, drugs, and bioactive peptides.

10. The method of claim 9 , wherein the bioactive peptide RGD is present.

11. The method of claim 9 , wherein a bioactive peptide is present and is a substrate for transglutaminase.

12. The method of claim 11 , wherein the bioactive peptide APQQEA is present.

13. The method of claim 11 , wherein the growth factor TGF-β or BMP is present.

Continuity (2)
Division 0915682900 · Sep 18, 1998
Related Publication 20040072793A1 · Apr 15, 2004